The Supreme Court has halted Purdue Pharma’s bankruptcy settlement, which would have shielded the Sackler family from liability in the opioid crisis. The order, issued without a breakdown of the justices’ votes, directs the parties to present their arguments before the high court in December. Purdue Pharma, controlled by the billionaire Sackler family, faced numerous lawsuits for its unethical marketing strategies that contributed to the nation’s opioid epidemic. The company filed for bankruptcy in 2019 and later reached a reorganization agreement to dissolve Purdue and establish a new company called Knoa Pharma. However, the Justice Department argues that the bankruptcy court lacked the authority to grant personal immunity to the Sackler family. This decision by the Supreme Court will address that question.
Since the CDC began tracking data on drug overdoses, over 1 million Americans have died from overdoses, highlighting the severity of the opioid crisis. Research has shown that Purdue Pharma exerted significant pressure on salespeople to promote OxyContin, despite its potential for harm. This pressure, coupled with the addictive nature of the prescription drug, has led some individuals to turn to street drugs like heroin when unable to access prescriptions. Despite these findings, former Purdue executive Richard Sackler has denied the family’s responsibility for the crisis.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
